Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Sensitivity (95% CI) (%)</td><td class="align_center">84.2 (60.4–96.6)</td></tr><tr><td class="align_left">Specificity (95% CI) (%)</td><td class="align_center">100 (2.5–100)</td></tr><tr><td class="align_left">PPV (95% CI) (%)</td><td class="align_center">100 (79.4–100)</td></tr><tr><td class="align_left">NPV (95% CI) (%)</td><td class="align_center">25.0 (0.6–80.6)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>CI: confidence interval; PPV: positive predictive value; NPV: negative predictive value.<br/></td></tr></table>

Clinical performance characteristics of two consecutive fecal-calprotectin &lt; 250 <i>μ</i>g/g as a surrogate marker of mucosal healing after treatment for active ulcerative colitis.

Gastroenterology Research and Practice

tab3

Table 3

Table 3: Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis 